226 related articles for article (PubMed ID: 21268285)
1. Zinc-finger-based transcriptional repression of rhodopsin in a model of dominant retinitis pigmentosa.
Mussolino C; Sanges D; Marrocco E; Bonetti C; Di Vicino U; Marigo V; Auricchio A; Meroni G; Surace EM
EMBO Mol Med; 2011 Mar; 3(3):118-28. PubMed ID: 21268285
[TBL] [Abstract][Full Text] [Related]
2. CRISPR genome surgery in a novel humanized model for autosomal dominant retinitis pigmentosa.
Wu WH; Tsai YT; Huang IW; Cheng CH; Hsu CW; Cui X; Ryu J; Quinn PMJ; Caruso SM; Lin CS; Tsang SH
Mol Ther; 2022 Apr; 30(4):1407-1420. PubMed ID: 35150888
[TBL] [Abstract][Full Text] [Related]
3. Mutation-independent rhodopsin gene therapy by knockdown and replacement with a single AAV vector.
Cideciyan AV; Sudharsan R; Dufour VL; Massengill MT; Iwabe S; Swider M; Lisi B; Sumaroka A; Marinho LF; Appelbaum T; Rossmiller B; Hauswirth WW; Jacobson SG; Lewin AS; Aguirre GD; Beltran WA
Proc Natl Acad Sci U S A; 2018 Sep; 115(36):E8547-E8556. PubMed ID: 30127005
[TBL] [Abstract][Full Text] [Related]
4. Repair of rhodopsin mRNA by spliceosome-mediated RNA trans-splicing: a new approach for autosomal dominant retinitis pigmentosa.
Berger A; Lorain S; Joséphine C; Desrosiers M; Peccate C; Voit T; Garcia L; Sahel JA; Bemelmans AP
Mol Ther; 2015 May; 23(5):918-930. PubMed ID: 25619725
[TBL] [Abstract][Full Text] [Related]
5. AAV delivery of wild-type rhodopsin preserves retinal function in a mouse model of autosomal dominant retinitis pigmentosa.
Mao H; James T; Schwein A; Shabashvili AE; Hauswirth WW; Gorbatyuk MS; Lewin AS
Hum Gene Ther; 2011 May; 22(5):567-75. PubMed ID: 21126223
[TBL] [Abstract][Full Text] [Related]
6. Genomic form of rhodopsin DNA nanoparticles rescued autosomal dominant Retinitis pigmentosa in the P23H knock-in mouse model.
Mitra RN; Zheng M; Weiss ER; Han Z
Biomaterials; 2018 Mar; 157():26-39. PubMed ID: 29232624
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy in animal models of autosomal dominant retinitis pigmentosa.
Rossmiller B; Mao H; Lewin AS
Mol Vis; 2012; 18():2479-96. PubMed ID: 23077406
[TBL] [Abstract][Full Text] [Related]
8. A transgenic mouse model for gene therapy of rhodopsin-linked Retinitis Pigmentosa.
O'Reilly M; Millington-Ward S; Palfi A; Chadderton N; Cronin T; McNally N; Humphries MM; Humphries P; Kenna PF; Farrar GJ
Vision Res; 2008 Feb; 48(3):386-91. PubMed ID: 17920651
[TBL] [Abstract][Full Text] [Related]
9. Progress in Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa.
Sudharsan R; Beltran WA
Adv Exp Med Biol; 2019; 1185():113-118. PubMed ID: 31884598
[TBL] [Abstract][Full Text] [Related]
10. Mirtron-mediated RNA knockdown/replacement therapy for the treatment of dominant retinitis pigmentosa.
Orlans HO; McClements ME; Barnard AR; Martinez-Fernandez de la Camara C; MacLaren RE
Nat Commun; 2021 Aug; 12(1):4934. PubMed ID: 34400638
[TBL] [Abstract][Full Text] [Related]
11. The nature of dominant mutations of rhodopsin and implications for gene therapy.
Wilson JH; Wensel TG
Mol Neurobiol; 2003 Oct; 28(2):149-58. PubMed ID: 14576453
[TBL] [Abstract][Full Text] [Related]
12. Challenging Safety and Efficacy of Retinal Gene Therapies by Retinogenesis.
Marrocco E; Maritato R; Botta S; Esposito M; Surace EM
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071252
[TBL] [Abstract][Full Text] [Related]
13. Knockout and Replacement Gene Surgery to Treat Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Sun X; Liang C; Chen Y; Cui T; Han J; Dai M; Zhang Y; Zhou Q; Li W
Hum Gene Ther; 2024 Mar; 35(5-6):151-162. PubMed ID: 38368562
[TBL] [Abstract][Full Text] [Related]
14. Autosomal dominant retinitis pigmentosa rhodopsin mutant Q344X drives specific alterations in chromatin complex gene transcription.
Bales KL; Ianov L; Kennedy AJ; Sweatt JD; Gross AK
Mol Vis; 2018; 24():153-164. PubMed ID: 29463953
[TBL] [Abstract][Full Text] [Related]
15. Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa.
Tsai YT; Wu WH; Lee TT; Wu WP; Xu CL; Park KS; Cui X; Justus S; Lin CS; Jauregui R; Su PY; Tsang SH
Ophthalmology; 2018 Sep; 125(9):1421-1430. PubMed ID: 29759820
[TBL] [Abstract][Full Text] [Related]
16. Therapy in Rhodopsin-Mediated Autosomal Dominant Retinitis Pigmentosa.
Meng D; Ragi SD; Tsang SH
Mol Ther; 2020 Oct; 28(10):2139-2149. PubMed ID: 32882181
[TBL] [Abstract][Full Text] [Related]
17. Gene delivery of wild-type rhodopsin rescues retinal function in an autosomal dominant retinitis pigmentosa mouse model.
Mao H; Gorbatyuk MS; Hauswirth WW; Lewin AS
Adv Exp Med Biol; 2012; 723():199-205. PubMed ID: 22183334
[TBL] [Abstract][Full Text] [Related]
18. Improved retinal function in a mouse model of dominant retinitis pigmentosa following AAV-delivered gene therapy.
Chadderton N; Millington-Ward S; Palfi A; O'Reilly M; Tuohy G; Humphries MM; Li T; Humphries P; Kenna PF; Farrar GJ
Mol Ther; 2009 Apr; 17(4):593-9. PubMed ID: 19174761
[TBL] [Abstract][Full Text] [Related]
19. Suppression and replacement gene therapy for autosomal dominant disease in a murine model of dominant retinitis pigmentosa.
Millington-Ward S; Chadderton N; O'Reilly M; Palfi A; Goldmann T; Kilty C; Humphries M; Wolfrum U; Bennett J; Humphries P; Kenna PF; Farrar GJ
Mol Ther; 2011 Apr; 19(4):642-9. PubMed ID: 21224835
[TBL] [Abstract][Full Text] [Related]
20. RNA interference-mediated suppression and replacement of human rhodopsin in vivo.
O'Reilly M; Palfi A; Chadderton N; Millington-Ward S; Ader M; Cronin T; Tuohy T; Auricchio A; Hildinger M; Tivnan A; McNally N; Humphries MM; Kiang AS; Humphries P; Kenna PF; Farrar GJ
Am J Hum Genet; 2007 Jul; 81(1):127-35. PubMed ID: 17564969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
